Agilent
In Brief This Week: PerkinElmer, Chembio, Becton Dickinson, Fulgent Genetics, and More
News items for the in vitro diagnostic industry for the week of Sept. 20, 2021.
Agilent, Visiopharm Ink Distribution Agreement for AI-Based Digital Pathology Software
Agilent said the agreement marks its entry into digital pathology and expands the scope of a long-term collaboration with Danish firm Visiopharm.
Agilent Technologies Gets CE-IVD Mark for Expanded Use of PD-L1 CDx in Esophageal Cancer
Last month, the test received CE marking as a companion diagnostic in patients with non-small cell lung cancer.
Agilent Technologies, Partek Partner on End-to-End Bioinformatics Workflow
Partek said that integrating its Partek Flow software with Agilent's clinical and research applications enables use of visualization tools for DNA and RNA applications.
Agilent Technologies Q3 Revenues Rise 26 Percent
Revenues for Agilent's diagnostic and genomics group rose 44 percent to $346 million from $241 million in the year-ago quarter.
May 25, 2021
Agilent Q2 Revenues Rise 23 Percent
Apr 14, 2021
Mar 9, 2021
Agilent Receives CE Mark for SARS-CoV-2 PCR Test
Mar 4, 2021
Mar 4, 2021
Agilent Prices $850M Senior Notes Offering
Feb 24, 2021
Nov 23, 2020